调脂治疗对不稳定型心绞痛患者血浆炎症因子的影响分析  

Lipid Adjusting Treatment of Unstable Angina Patients Plasma Proinflammatory Factor Influence Analysis

作　　者：尹咏红 

机构地区：[1]平江县第一人民医院,湖南岳阳414500

出　　处：《中外医疗》2011年第18期12-12,14,共2页China & Foreign Medical Treatment

摘　　要：目的探讨调脂治疗对不稳定型心绞痛患者血浆炎症因子的影响。方法检测85例不稳定型心绞痛患者服用阿托伐他汀前后血浆单核细胞趋化因子-1及超敏C反应蛋白水平。结果不稳定型心绞痛患者的血浆单核细胞趋化因子-1及超敏C反应蛋白水平显著高于健康对照组(P<0.05),服用阿托伐他汀4周后其水平明显下降(P<0.05)。结论不稳定型心绞痛患者血浆单核细胞趋化因子-1及超敏C反应蛋白水平升高与冠脉炎症反应相关,阿托伐他汀可显著降低其水平。改善冠心病患者的预后。Objective tiaozhi treatment of unstable angina patients plasma proinflammatory factor influence.Methods detection 85 cases of unstable angina patients were receiving atorvastatin before and after plasma mononuclear cells chemotactic factors-1 and allergic c-reactive protein level.Results the unstable angina patients plasma mononuclear cells chemotactic factors-1 and allergic c-reactive protein level of health is significantly higher than control group（P0.05）,taking atorvastatin 4 weeks after its level decreased obviously（P0.05）.Conclusion unstable angina patients plasma mononuclear cells chemotactic factors-1 and allergic c-reactive protein eleations and coronary inflammation related,atorvastatin can significantly reduce its level.To improve the prognosis of patients with coronary heart disease.

关 键 词：阿托伐他汀 心绞痛 炎症因子 

分 类 号：R541[医药卫生—心血管疾病]